Daniel Thomas

A €5 million reactor order for a nearly invisible component is sending shockwaves through the semiconductor industry, signaling a critical shift in how the world’s most advanced chips are made.

A new deal between miner Elevra and refiner Mangrove, backed by Ottawa's strategic investment, creates a complete Canadian lithium supply chain from mine to battery material.

An Ottawa developer is offering homes at 2019 prices, testing if government incentives and advanced manufacturing can finally deliver on affordability.

Johnsonville's new deal with the Joe Moore Award is more than a sponsorship; it's a savvy investment in the unsung heroes and communal spirit of college football.

One of America’s fastest-growing remodelers is planting a flag in Charleston. But is its high-growth blueprint a boon for the local economy or a storm warning for local contractors?

Coultreon Biopharma's strategic hire of Dr. Prista Charuworn signals a major push to advance its novel SIK3 inhibitor in the crowded autoimmune market.

A Boston biotech with Korean roots just went public in Seoul. Its goal: to repair the body's smallest blood vessels, a market Merck has already bet billions on.

A pact between American Rare Earths and Novex tackles the critical chokepoint in the U.S. supply chain: turning oxide into metal for high-tech magnets.

As Olive Young launches its first U.S. festival, brands like COSRX are trading shelf space for immersive 'playgrounds' to educate and capture the American consumer.

Biomea Fusion's new trial combines its drug icovamenib with semaglutide, aiming not just for weight loss, but to solve a major side effect: muscle loss.

AGF Investments is slashing fees on its Elements portfolios, a move that benefits investors but signals intense pressure on active managers from low-cost rivals.

South Korea's PharmaResearch is strategically embedding its REJURAN skin booster in Australia, moving beyond sales to reshape aesthetics with science and education.

As MLB returns to Iowa's Field of Dreams on Netflix, the real story isn't just the game. It's how German brand STRAUSS is using the global stream to build its US presence.

A new partnership between Dumpsters.com and Blue Point Capital aims to transform the $100B waste industry with an asset-light tech platform and big capital.

Merit Financial's latest acquisition is more than a line item. It’s a story of industry consolidation, advisor exodus, and the strategic hunt for scale.

A traditional construction firm is set to become a pure-play AI robotics company on the NYSE. Why is JFB betting it all on XTEND's autonomous technology?

Two Harbors fires back at a "baseless" lawsuit from UWM, exposing a financial firestorm centered on a massive derivatives loss and a failed merger.

As big banks retreat, a credit union and a community anchor are forging a new model for financial inclusion. Is this the future of urban investment?

As schools face a fiscal cliff with federal funds gone, one company's free, hands-on tech tour reveals a new strategy for survival and market share.

As Parkinson's cases surge, an innovative fellowship trains nurse practitioners to bridge a critical care gap, creating a new model for chronic disease.